News Room
TP-102 clinical trial presented at ECCMID 2023
Last month Technophage team attended 33rd European Congress of Clinical Microbiology & Infectious Diseases with the clinical team from Israel,...
Technophage featured in ‘The Economist’
Technophage has been featured in 'The Economist' journal. The piece entitled ‘Western firms are becoming interested in a Soviet medicine’ describes...
Visit of delegation of Macau to Lisbon with Technophage’s presence
In the scope of the “Visit of delegation led by Chief Executive of Macao SAR and University of Macau Delegation to the University of Lisbon”,...
Pipeline
Invest in our products
GMP manufacturing
Learn more about GMP manufacturing
Technophage
Who we are, What we do
Therapeutic
areas
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology